ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway

(2019) Meng-Yao Sun et al.   Frontiers in Pharmacology

Role of TGF-β activated kinase-1 inhibitor on the interaction between macrophages and mesangial cells on the condition of high glucose

(2018) Zhe Fan et al.   IMMUNOLOGICAL INVESTIGATIONS

Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy

(2018) Ditmer T. Talsma et al.   LABORATORY INVESTIGATION

Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives

(2018) Peter Rossing et al.   Nephrologie & Therapeutique

Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial

(2018) Xue-min Zhao et al.   Trials

Herbal Compound “Jiedu Huayu” Reduces Liver Injury in Rats via Regulation of IL-2, TLR4, and PCNA Expression Levels

(2017) Minggang Wang et al.   Evidence-based Complementary and Alternative Medicine

Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway

(2017) Fei Han et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Chinese medicine for diabetic kidney disease in China

(2017) Yumin Wen et al.   NEPHROLOGY

Are the Therapeutic Effects of Huangqi (Astragalus membranaceus) on Diabetic Nephropathy Correlated with Its Regulation of Macrophage iNOS Activity?

(2017) Hui Liao et al.   Journal of Immunology Research

MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy

(2016) Kate Simpson et al.   Current Diabetes Reports

JAK inhibition in the treatment of diabetic kidney disease

(2016) Frank C. Brosius et al.   DIABETOLOGIA

Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway

(2016) Ting He et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

SP338ACTIVATION OF CXCL16/CXCR6 PATHWAY BY INFLAMMATION ACCELERATES THE PROGRESSION OF DIABETIC NEPHROPATHY

(2016) Ze Bo Hu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial

(2016) Meihua Yan et al.   Trials

Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes

(2016) Kanna Nagaishi et al.   Scientific Reports

Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy

(2015) C. Hu et al.   CURRENT MEDICINAL CHEMISTRY

C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease

(2015) Ling Li et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction

(2013) Kiyomi Koike et al.   CLINICAL IMMUNOLOGY

Hrd1 participates in the regulation of collagen I synthesis in renal fibrosis

(2013) Lei Li et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Inflammation and the pathogenesis of diabetic nephropathy

(2012) Jun Wada et al.   CLINICAL SCIENCE

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

(2011) Juan F. Navarro-González et al.   Nature Reviews Nephrology